Research funder · United States
BrightFocus Foundation
Non-profit organization in the USA
- Grants since 2016
- 717
- Awarded, last 5 years (where amounts are published)
- $108M
- Funded works, last 5 years
- 1 862
- Funded works, all time
- 3 290
Grants
2021–2024 · research · National Glaucoma Research: Standard
In vivo characterization of the mechanical properties of the human optic nerve head
Thao Nguyen · Johns Hopkins University
2021–2026 · research · Alzheimer's Disease Research: Standard
International Society for Molecular Neurodegeneration
Henrietta Nielsen · Stockholm University
2021–2025 · research · Alzheimer's Disease Research: Standard
Pericyte Neuron Crosstalk and the Progression of Alzheimer's Disease
Melanie Samuel · Baylor College of Medicine
2021–2023 · fellowship · Alzheimer's Disease Research: Postdoctoral Fellowship
Tau Phosphorylation in Preclinical and Symptomatic Autosomal Dominant Alzheimer Disease
Karin Meeker · Washington University in St. Louis
2021–2024 · research · Alzheimer's Disease Research: Standard
Immune mechanisms of synapse loss in Alzheimer’s disease
Soyon Hong · University College London
2021–2025 · fellowship · Macular Degeneration Research: Postdoctoral Fellowship
Ciliary lipids in RPE repair: a novel target for AMD
Ke Ning · Stanford University
2021–2026 · research · National Glaucoma Research: Standard
Low cost community glaucoma screening in West Africa
Michael Hauser · Duke University
2021–2023 · fellowship · National Glaucoma Research: Postdoctoral Fellowship
Hemodynamics and biomechanics of the monkey lamina cribrosa
Yi Hua · University of Pittsburgh
2021–2024 · research · National Glaucoma Research: Bold Ideas initiatives
Selective Targeting of Schlemm's Canal Inner Wall for Next-Generation Glaucoma Drugs: Subpart C
Darryl Overby · Imperial College London
2021–2023 · fellowship · Macular Degeneration Research: Postdoctoral Fellowship
Novel Frizzled-4/LRP5 antibody-based agonist for neovascular macular degeneration
Rony Chidiac · University of Toronto
2021–2024 · research · Alzheimer's Disease Research: Bold Ideas initiatives
Advancing the Promising Cerebroprotectant AST-004 to Human Traumatic Brain Injury Clinical Trials
William Korinek · Astrocyte Pharmaceuticals
2021–2023 · research · Macular Degeneration Research: Standard
Regulation of Macrophage-Mediated Neovascular Remodeling in Neovascular AMD
Priyatham Mettu · Duke University
2021–2023 · fellowship · Alzheimer's Disease Research: Postdoctoral Fellowship
Molecular mechanisms of axonal pathology in Alzheimer's disease
Yifei Cai · Shanghai Jiao Tong University
2021–2024 · fellowship · Macular Degeneration Research: Postdoctoral Fellowship
Macular and Mid-Peripheral Specific iPSC-RPE Models to Discover Regional RPE Susceptibility in AMD
Davide Ortolan · National Eye Institute
2021–2023 · fellowship · Macular Degeneration Research: Postdoctoral Fellowship
CryoEM Structure-based Development of HTRA1 Specific Inhibitors for Age-related Macular Degeneration
Young Joo Sun · Stanford University
2021–2025 · research · Alzheimer's Disease Research: Standard
Detecting and characterizing preclinical AD using AI and structural MRI
Aristeidis Sotiras · Washington University in St. Louis
2021–2023 · fellowship · Macular Degeneration Research: Postdoctoral Fellowship
Addressing the link about impairment in phagosome degradation and AMD
Antonio Escudero Paniagua · University of California, Los Angeles
2021–2025 · research · Alzheimer's Disease Research: Standard
APOE genotype-dependent effects of life-style intervention in healthy aging and Alzheimer's disease
Na Zhao · Mayo Clinic in Florida
2021–2023 · research · Alzheimer's Disease Research: Bold Ideas initiatives
Advancement of Drugs for the Treatment of Repeated Mild Traumatic Brain Injury (mTBI)
Patrick Sullivan · University Of Kentucky Research Foundation
2021–2023 · fellowship · Alzheimer's Disease Research: Postdoctoral Fellowship
Nucleus incertus of the brain: mapping its genomic expression and changes in Alzheimer's disease
Camila De Avila Dal Bo · Arizona State University
2021–2023 · fellowship · Alzheimer's Disease Research: Postdoctoral Fellowship
The role of the peripheral immune-system in FTD-GRN; increasing understanding for future therapeutic target development
Rebecca Wallings · Indiana University
2021–2024 · research · Macular Degeneration Research: Other
Macrophage origin, heterogeneity, and function during experimental choroidal neovascularization in mice
Jeremy Lavine · Northwestern University
2021–2023 · fellowship · Macular Degeneration Research: Postdoctoral Fellowship
Exploring the role of Hepatic lipase and lipid metabolism in AMD pathogenesis
Rohini M Nair · University of Pennsylvania
2021–2023 · research · National Glaucoma Research: Standard
New neuroprotective genes against axonal damage and glaucoma
Matthew Veldman · Medical College of Wisconsin
2021–2020 · research · Macular Degeneration Research: Standard
Investigating the role of PGC-1beta in neovascular AMD
Magali Saint-Geniez · Massachusetts Eye and Ear Infirmary
2021–2036 · research · Alzheimer's Disease Research: Standard
Molecular Neurodegeneration Journal
Owen Ross · Mayo Clinic
2021–2023 · fellowship · Alzheimer's Disease Research: Postdoctoral Fellowship
The brainstem locus coeruleus: potential bridge between sleep-wake disruption and Alzheimer's disease pathogenesis
Maxime Van Egroo · Maastricht University
2021–2025 · research · Alzheimer's Disease Research: Standard
The role of HIF-1a in the microglial response to Alzheimer’s disease pathology
Jonas Neher · German Center for Neurodegenerative Diseases
2021–2023 · fellowship · Macular Degeneration Research: Postdoctoral Fellowship
Understanding the role of Akt2 signaling in inflammatory processes in age-related macular degeneration (AMD)
Sayan Ghosh · University of Pittsburgh
2021–2024 · research · Alzheimer's Disease Research: Standard
The microbiota cell-type specific regulation of AD pathogenesis
Laura Cox · Brigham and Women's Hospital
2021–2025 · research · National Glaucoma Research: Bold Ideas initiatives
Selective Targeting of Schlemm's Canal Inner Wall for Next-Generation Glaucoma Drugs: Subpart B
W. Daniel Stamer · Duke University
2021–2023 · research · National Glaucoma Research: Standard
Mapping scleral fibroblasts and their significance in glaucoma.
Ian Pitha · Johns Hopkins University
2021–2025 · research · Alzheimer's Disease Research: Standard
The role of peripheral apoE in the high density lipoprotein fraction in vascular contributions to Alzheimer’s Disease
Cheryl Wellington · University of British Columbia
2021–2024 · research · Alzheimer's Disease Research: Standard
De-Phosphorylation of Tau by Chaperone Complexes
Jason Gestwicki · University Of California
2021–2023 · fellowship · Alzheimer's Disease Research: Postdoctoral Fellowship
Determining mechanisms of age-related cerebrovascular dysfunction in a genetic model of cerebral small vessel disease
Xiaowei Wang · The University Of California
2021–2023 · fellowship · Alzheimer's Disease Research: Postdoctoral Fellowship
The Landscape and Expression of APOE Transcripts in human brain and Alzheimer's Disease
Emil Gustavsson · University College London
2021–2024 · fellowship · Alzheimer's Disease Research: Postdoctoral Fellowship
Restoring sleep and memory deficits in Alzheimer's disease by targeting somatostatin interneurons
Moustafa Algamal · Massachusetts General Hospital
2021–2023 · fellowship · Alzheimer's Disease Research: Postdoctoral Fellowship
Characterizing the role of microglial GPR56 in Alzheimer’s disease
Beika Zhu · University of California, San Francisco
2021–2025 · research · National Glaucoma Research: Bold Ideas initiatives
Selective Targeting of Schlemm's Canal Inner Wall for Next-Generation Glaucoma Drugs: Subpart A
Christopher Ethier · Georgia Institute of Technology
2021–2025 · research · Alzheimer's Disease Research: Standard
Pathophysiology of sRNAs in Alzheimer Disease
Laura Ibanez · Washington University in St. Louis